SEC Form 4 · accession 0001209191-15-015870
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nikin Patel
Officer — CEO, Molecular Profiles · Director
Period of report
Feb 11, 2015
Accepted (ET)
Feb 19, 2015 · 12:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to buy) | $5.56 | Feb 11, 2015 | A | 32,000 | A | May 11, 2015 | Feb 11, 2022 | $0.01 par value of Common Stock | 32,000 | 32,000 | D |